Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:16 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:16 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Zacks News
Kroger, Microsoft Partner for Connected Store Pilot Program
by Zacks Equity Research
Kroger (KR) collaborates with Microsoft to leverage RaaS in enhancing customer's online shopping experience, using the latter's cloud based platform.
Pharmacies & Drug Stores Industry Outlook: Prospects Look Weak
by Zacks Equity Research
Pharmacy retailers are gradually realizing the growing market demand for Medicare plan options. This apart, they are aggressively emphasizing on chronic disease care and management.
Walgreens Boots Alliance (WBA) Stock Moves -1.04%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $67.33, moving -1.04% from the previous trading session.
Walgreens Counts on International Progress, Strategic Deals
by Zacks Equity Research
We are upbeat about Walgreens' (WBA) recent pact with Alphabet???s life sciences and healthcare segment, Verily, to coordinate on multiple projects with respect to chronic ailments.
Zacks Investment Ideas feature highlights: Tesla, Walgreen Boots Alliance and Oracle
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Tesla, Walgreen Boots Alliance and Oracle
Why Did Tesla (TSLA) Stock Climb Today?
by Ryan McQueeney
Shares of Tesla (TSLA) added nearly 5% on Friday after the company announced the appointment of Larry Ellison and Kathleen Wilson-Thompson to its board of directors.
Positive Management Changes Boost Tesla Shares
by David Borun
Kathleen Wilson-Thompson and Larry Ellison strengthen the Board of Directors at Tesla
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $68.36, marking a +0.95% move from the previous day.
Amazon Posts Record-Breaking Holiday Sales: Time to Buy AMZN Stock?
by Benjamin Rains
Shares of Amazon (AMZN) popped 5% in morning trading the day after Christmas after the e-commerce powerhouse said that its customers made more purchases worldwide than ever before during the holiday season. The question now is should investors consider buying Amazon stock on the dip as we move into 2019?
5 Worst Performing Stocks of Dow ETF Last Week
by Sweta Killa
Dow Jones suffered its worst week since the global financial crisis of 2008. We have highlighted five worst-performing stocks in the ETF.
The Zacks Analyst Blog Highlights: Alphabet, Walgreens Boots, Johnson & Johnson and Amazon
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, Walgreens Boots, Johnson & Johnson and Amazon
Alphabet Ties Up with Walgreens, Boosts Healthcare Presence
by Zacks Equity Research
Alphabet's (GOOGL) Verily joins forces with Walgreens Boots Alliance to trim the healthcare cost for the patients with the aid of technology.
Company News For Dec 21, 2018
by Zacks Equity Research
Companies In The News Are: WBA,BB,CCL,TLRY,BUD
Dow 30 Stock Roundup: Nike, Walgreens Boots Earnings Impress
by Swarup Gupta
The Dow suffered a particularly tough week, weighed down by a number of concerns.
Walgreens (WBA) Q1 Earnings Top Estimates, Margins Down
by Zacks Equity Research
Walgreens' (WBA) retail Pharmacy USA division witnessed comparable prescription growth and benefited from a strong retail prescription market.
Rite Aid (RAD) Stock Up on Q3 Earnings Beat, FY19 View Down
by Zacks Equity Research
Rite Aid's (RAD) top and bottom lines improve year over year. Also, earnings came ahead of the Zacks Consensus Estimate but sales lagged the same.
Walgreens-Alphabet Join Forces to Control Healthcare Costs
by Zacks Equity Research
Walgreens (WBA) and Alphabet's arm Verily to start a medication adherence pilot project that will deploy equipment and other methods to improve adherence.
Walgreens Boots Alliance (WBA) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 2.10% and 0.62%, respectively, for the quarter ended November 2018. Do the numbers hold clues to what lies ahead for the stock?
Will the Fed Notice Oil's Crash? & Today's Stocks to Watch: MU, FDX, WBA
by Ryan McQueeney
Ryan McQueeney discusses the crash in oil prices and the Fed's monthly meeting. He also recaps earnings from FedEx and Micron. Later, Ryan takes a look at upcoming reports from Walgreens and Nike.
Will Walgreens (WBA) Q1 Earnings Gain From Overall Strength?
by Zacks Equity Research
Several planned developments, early benefits from new pharmacy contracts as well as increased volumes are consistently driving growth within Walgreens Boots' (WBA) Retail Pharmacy USA division.
Upcoming Earnings to Watch: MU, NKE, WBA
by Ryan McQueeney
A new earnings season is also on the horizon, and a fresh batch of companies have the opportunity to ease Wall Street's nerves if they can post strong results. Here's a look at a few of the earnings announcements due during the week of December 17.
Buy Amazon (AMZN) Stock on the Dip Heading into 2019?
by Benjamin Rains
Amazon (AMZN) stock has fallen over 16% in the last three months as part of the larger market pullback driven by the likes of Apple (AAPL) and other giants. The company's days of 40% top-line growth might also be over. But let's dive into Amazon's overall business picture and outlook to see if investors should buy AMZN stock heading into 2019.
Walgreens Boots Alliance (WBA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Walgreens Boots, Duke Energy, Stryker, Kinder Morgan and PepsiCo
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walgreens Boots, Duke Energy, Stryker, Kinder Morgan and PepsiCo
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $82.44 in the latest trading session, marking a +0.77% move from the prior day.